MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Johnson and Johnson executive splits for the corner office at Itamar Medical | Personnel Moves

Johnson and Johnson executive splits for the corner office at Itamar Medical | Personnel Moves

By

fired/hired

 Former J&J executive joins Itamar Medical as CEO
Gilad Glick will leave his job as head of Johnson & Johnson’s (NYSE:JNJ) global cardiology division to become the CEO of Itamar Medical in July.

The Caesarea, Israel-based medical device maker said current CEO, Dov Rubin, will step down after serving for 5 years. The company calls this a "pivotal point of transitionally into an accelerated commercial stage."

Glick joined Biosense Webster while it was still a small start up, before it was sold to Johnson and Johnson as part of company’s cardiovascular division. While at Johnson and Johnson, Glick served as VP of worldwide sales and marketing and as a senior member of the Biosense team.
Read more

 Interim CEO step up, VP of finance steps down at Vision-Sciences
Vision-Sciences Inc. (NSDQ:VSCI) appointed an interim CEO to replace Cynthia Ansari, who stepped down after 2 years at the job. Howard I. Zauberman was appointed based on his 30 years of experience in the medical device industry. The Orangeburg, S.C.-based endoscopic device maker also announced resignation of Keith Darragh, the company’s VP of finance and accounting officer.
Read more

 New VP of global sales and marketing at Misonix

Misonix (NSDQ:MSON) appointed Scott Ludecker VP of global sales and marketing. He joins the company from the same role at BioMimetic Therapeutics. Ludecker has more than 20 years experience in the global medical device industry, most recently at BioMimetic and Small Bone Innovations. According to the April 8 offer letter, Ludecker will receive a base salary of $200,000 and report directly to CEO Michael McManus, Jr.
Read more

 Third Rock Ventures pulls in industry executives
Venture capital firm Third Rock recently appointed several new executives from large pharmaceutical and medical device companies.

The Boston, Mass.-based VC named James Geraghty as entrepreneur-in-residence. Geraghty comes to Third Rock with 20 years experience at Genzyme Corporation. Steven Paul will be stepping up his role as a venture partner. He is a former Lilly Research Labs president and director of the Helen & Robert Appel Institute for Alzheimer’s Research at Weill Cornell Medical College. Daniel Lynch, former CEO of ImClone Systems, will transition from entrepreneur-in-residence to a venture partner. John Maraganore, CEO of Alnylam, also joined the Third Rock as a venture partner.
Read more

 New CEO joins Accumed Radial Systems
Michael Pisano joined Accumed Radial Systems as president and CEO. Pisano will lead the the newly formed wholly owned subsidiary of Accumed Systems, Inc. The newly formed Accumed Radial Systems was created after successful roll out of several transradial procedures by Accumed Systems, which decided to create the subsidiary to focus solely on this market. Pisano formerly worked as CEO of NextGen Group.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • House committee investigates $70M federal contract for AutoMedx ventilators
    A Congressional committee has launched an investigation into a $70 million White House contract for ventilators that reportedly are inadequate to treat people with COVID-19. The Department of Defense signed a $16.2 million contract in spring 2020 to buy SAVe II ventilators, manufactured by AutoMedx (Addison, Tex.), from the supplier Combat Medical Systems, according to… […]
  • How CGMs can inspire lifestyle changes
    As an early adopter of fitness trackers such as the Fitbit, I’ve long appreciated the power of health data. But my recent experience with a continuous glucose monitor (CGM) has done far more to inspire me to look after my health — even as a nondiabetic. I had heard about the potential of such technology… […]
  • COVID-19 mask factory opens in N.J.
    Hudson Holdings Group today announced it has opened a factory to make up to tens of millions of protective masks a month. The Piscataway, N.J., site will produce more than 200 jobs, according to the company, which is in partnership on the project with the State of New Jersey. “Our ultimate goal is to help,”… […]
  • TE Connectivity posts Street-beating Q1 results, medical sales dip 12%
    TE Connectivity (NYSE:TEL) posted first-quarter results today that beat the consensus on Wall Street. The Schaffhausen, Switzerland-based company reported profits of $381 million, or $1.13 per share, on sales of $3.5 billion for the three months ended Dec. 31, 2020, for a bottom-line gain of 1365.4% sales growth of 11.2% compared with Q1 2020. Adjusted to… […]
  • Could this 3-D printed ‘biomesh’ minimize hernia repair complications?
    Some hernia mesh implants have been associated with adverse post-surgical complications. So researchers at Baylor College of Medicine have developed a 3D-printed biomesh to support and reinforce the damaged abdominal wall and facilitate the healing process. Mesh implants may fail because they promote the adhesion of the intestine, liver or other visceral organs to the… […]
  • Superior Sensor Technology launches versatile differential pressure sensors
    Superior Sensor Technology (Santa Clara, Calif.) today announced the launch of differential pressure sensors for industrial applications that support up to seven selectable pressure ranges in one device. Designed for a wide range of applications, the new ND Series sensors support pressure ranges as low as 62.5 Pa/0.25” H2O to as high as 345 mBar/5… […]
  • BD touts study of antigen test over molecular test for identifying infectious COVID-19 cases
    Becton Dickinson (BD) is touting the results of a small, in-house study of its Veritor Plus antigen test over molecular (PCR) tests to indicate whether an infected person is more likely able to spread SARS-CoV-2. The peer-reviewed study compared antigen and PCR test results to positive results using a viral cell culture test. Viral growth… […]
  • TDK adds pressure sensors for ventilators
    TDK Corporation announced the launch of a new range of differential pressure sensors designed as printed circuit boards for use in medical devices. The sensors are designed for measurement ranges of 16 mbar full-scale (FS), 100 mbar FS and 7 bar FS, with accuracy of up to ±1% FS at temperatures from -20 °C to… […]
  • Pediatric device workshop scheduled for February
    A virtual public meeting on pediatric medical device development is scheduled for Feb. 9-11, 2021. Sponsors include the FDA, AdvaMed, the American Academy of Pediatrics and the Critical Path Institute, a public-private partnership that receives FDA funding. The System of Hospitals for Innovation in Pediatrics – Medical Devices (SHIP-MD) Virtual Workshop will focus on the… […]
  • Pedra wins breakthrough nod for perfusion system
    Singapore-based Pedra Technology announced today that the FDA has granted the company breakthrough device designation for the periprocedural use of its Xauron perfusion system in the treatment of critical limb-threatening ischemia (CLTI). CLTI is a severe form of peripheral artery disease (PAD) that is defined as ischemic rest pain, tissue loss or gangrene (tissue death) that… […]
  • Freudenberg Medical expands U.S. molding operations
    Freudenberg Medical announced that it has expanded injection molding operations at its Baldwin Park, Calif., operation, which is focused on thermoplastics. Freudenberg Medical Baldwin Park has added six injection molding machines including three new Arburg molding machines, a work cell for two-shot molding and a Wittmann Battenfeld micro-molding machine with in-process visual inspection capability. The… […]

Leave a Reply